Stocks rose sharply on Thursday after the Federal Reserve hinted at possible interest rate cuts as soon as next month.US Marketsread more
The billionaire investor believes the stock market is in a "zone of fair value" at current levels.Marketsread more
The Federal Reserve may be on its way to delivering a half-point interest rate cut next month, according to Goldman Sachs economists.Economyread more
However, Slack chief Stewart Butterfield says, "The broader world of email will stick around."CNBC Disruptor 50read more
Crude oil prices jump on news of the attack, which Iran says happened over its territory.World Politicsread more
Apple is considering moving some production from China as it is expected release of its new iPhone line this fall, The Wall Street Journal reported.Technologyread more
Workplace messaging firm Slack is about to go public in a red-hot IPO market, but it's approach to going public--using a "direct listing"--is slightly different than an IPO.Trader Talk with Bob Pisaniread more
The yield on the benchmark 10-year Treasury note fell below 2% for the first time since November 2016 on Wednesday.Bondsread more
National Securities' Art Hogan sees the U.S.-China trade war as the market's biggest risk – not Fed policy.Trading Nationread more
The Philadelphia Federal Reserve's manufacturing gauge tumbled this month, solidifying the Fed's case for easier monetary policy.Economyread more
Declining traffic to Olive Garden, Darden's top restaurant chain, resulted in weaker-than-expected revenue for its fiscal fourth quarter.Restaurantsread more
CBD has become a popular fix for pet owners looking to treat their animals' anxiety and epilepsy.
But they won't be able to shop the cannabis compound at Chewy, the online pet product retailer owned by PetSmart, anytime soon.
"CBD is not something that I'm thinking about immediately," Chewy CEO Sumit Singh said Friday on CNBC's "Squawk on the Street " ahead of the e-commerce pet food retailer's market debut.
Singh said that the company would consider CBD "when it's legal," adding that the primary focus is expanding its assortment of products. The Food and Drug Administration hasn't approved cannabis products for human or animal consumption yet, and there is little data to prove that its use benefits pets.
Even without the FDA's go-ahead, sales of CBD pet products quadrupled last year to $32 million from $8 million in 2017, according to the Brightfield Group, a cannabis-focused research firm. And the group estimates that number could skyrocket to $1.16 billion in the U.S. alone by 2022.
Other mainstream retailers have begun selling CBD products in their stores. Major chains like Walgreens and Kroger have started selling topical products that contain the cannabis compound. Topical products like creams and oils carry less legal risk.
Even without CBD products, Chewy reported $3.5 billion in sales for fiscal 2018. The company has not turned a profit yet, joining a host of other unprofitable companies like Uber and Pinterest that are going public this year.
Shares of Chewy soared 77% Friday morning after pricing its IPO at $22 per share. The offering raised just over $1 billion, valuing the retailer at $8.8 billion. Following the offering, PetSmart will still own roughly 70% of the company's common stock and hold about 77% of its voting power.